Explore preclinical research on Selank and Pinealon neuropeptides: GABA-A modulation, epigenetic neuroprotection, and complementary rodent model findings.
Explore preclinical research on the CJC-1295 MOTS-c stack: GH axis amplification paired with mitochondrial AMPK activation across animal model studies.
Explore preclinical NAD+ Epithalon longevity research: sirtuin/PARP and telomere pathways, parallel aging hallmarks, and animal-model co-administration data.
NAD+ research in preclinical models reveals sirtuin activation, PARP competition, and mitochondrial effects. Review the evidence on NAD+ and longevity.
TB-500 (Thymosin Beta-4) research documents actin sequestration, angiogenesis, and muscle, tendon, and cardiac repair in preclinical animal models. Full review.
Melanotan-2 research covers MC1R and MC4R agonism, skin pigmentation in animal models, and neuroprotective melanocortin signalling in preclinical studies.
Orforglipron GLP-1 research: non-peptide small molecule, oral bioavailability, ATTAIN phase 3 data, and mechanistic comparison to semaglutide and tirzepatide.
Preclinical research on Pinealon (EDR tripeptide): epigenetic mechanisms, neuroprotective effects in animal models, and cognitive aging from the Khavinson lab.
Explore preclinical and clinical research on Tesamorelin, a 44-amino acid GHRH analog studied for visceral adiposity, GH pulse dynamics, and metabolic markers.
Preclinical research on CJC-1295, a GHRH analog studied for GH pulse amplification, IGF-1 axis modulation, and body composition effects in animal models.
THE STACK · RESEARCH NOTES
78 papers across 7 compound categories.